Literature DB >> 20078273

Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.

V S Baldwa1, C M Bhandari, A Pangaria, R K Goyal.   

Abstract

Clinical study of an insulin-like compound obtained from vegetable source (vegetable insulin) was carried out on nine patients with diabetes mellitus. The active hypoglycaemic principle, purified protein extract, was obtained from fruits as well as from tissue cultures of the plant Momordica charantia L. This extract was homologous to insulin obtained from animal pancreas. It showed a consistent hypoglycaemic effect in patients with diabetes mellitus. The average fall in blood sugar level at the peak effect of vegetable insulin was found to be statistically significant. The onset of action was within 30-60 min with the peak effect six hours after the administration of the dose of plant insulin. No hypersensitivity reaction to this extract was observed in the group of patients studied.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20078273     DOI: 10.3109/03009737709179057

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  19 in total

Review 1.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 2.  A review of the hypoglycemic effects of five commonly used herbal food supplements.

Authors:  Ruitang Deng
Journal:  Recent Pat Food Nutr Agric       Date:  2012-04-01

Review 3.  Complementary and alternative medicine for the treatment of type 2 diabetes.

Authors:  Richard Nahas; Matthew Moher
Journal:  Can Fam Physician       Date:  2009-06       Impact factor: 3.275

4.  Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes.

Authors:  E Cummings; H S Hundal; H Wackerhage; M Hope; M Belle; E Adeghate; J Singh
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

5.  Expression and characterization of Momordica Chanrantia anti-hyperglycaemic peptide in Escherichia coli.

Authors:  Si-Xiu Liu; Zhong-Ping Fu; Rui-Min Mu; Zhi-Bi Hu; Fu-Jun Wang; Xiang-Rong Wang
Journal:  Mol Biol Rep       Date:  2009-07-08       Impact factor: 2.316

6.  Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia.

Authors:  Siew Mooi Ching; Zainul Amiruddin Zakaria; Fuziah Paimin; Mehrdad Jalalian
Journal:  BMC Complement Altern Med       Date:  2013-06-26       Impact factor: 3.659

7.  Non-traditional therapies for diabetes: fact or fiction.

Authors:  Elena Forouhar; Paul Sack
Journal:  J Community Hosp Intern Med Perspect       Date:  2012-07-16

Review 8.  Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.

Authors:  Jimmy T Efird; Yuk Ming Choi; Stephen W Davies; Sanjay Mehra; Ethan J Anderson; Lalage A Katunga
Journal:  Int J Environ Res Public Health       Date:  2014-02-21       Impact factor: 3.390

Review 9.  Overview of Botanical Status in EU, USA, and Thailand.

Authors:  Weena Jiratchariyakul; Gail B Mahady
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-21       Impact factor: 2.629

10.  In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).

Authors:  Sundar Poovitha; Madasamy Parani
Journal:  BMC Complement Altern Med       Date:  2016-07-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.